Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
European Urology(2025)
Key words
Adjuvant therapy,Overall survival,Pembrolizumab,Tyrosine kinase inhibitor,High risk,Metastasectomy,Clear cell histology,Renal cell carcinoma
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined